Sulopenem etzadroxil

Unassigned

New Medicines

Uncomplicated urinary tract infection (especially fluoroquinolone resistant).

Information

New molecular entity
Iterum Therapeutics
Iterum Therapeutics

Development and Regulatory status

Phase III Clinical Trials
Phase III Clinical Trials
Phase III Clinical Trials

Category

Carbapenem antibiotic combined with probenecid
UTIs are among the most common bacterial infections encountered in the community. Up to 10% of women have a urinary tract infection in a given year and 50% of all women experience at least one UTI at some point in their lives [1].
Uncomplicated urinary tract infection (especially fluoroquinolone resistant).
Oral